We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Merck KGaA Buys Bangalore 'Omics Firm
News

Merck KGaA Buys Bangalore 'Omics Firm

Merck KGaA Buys Bangalore 'Omics Firm
News

Merck KGaA Buys Bangalore 'Omics Firm

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Merck KGaA Buys Bangalore 'Omics Firm"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Merck KGaA said that it has bought Bangalore Genei (India) Private (BGIP), which makes and sells 'omics tools, through its Merck Specialties subsidiary for an undisclosed sum.

Merck acquired the Bangalore-based firm, which specializes in making and selling genomics and proteomics research products, from the Sanmar Group. The company employs over 100 people and had revenues of around INR202 million ($4.4 million) in fiscal year 2009.

"BGIP's leadership in the Indian academic market, a segment with high growth potential, will ideally complement our existing customer base," Christina Shasserre, global head of Merck's bioscience business, said in a statement. "BGIP's product portfolio comprises a wide range of bioscience products, which are tailored to the needs of the domestic market in India."

Financial terms of the agreement were not released.
Advertisement